Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Douglas Abel Net Worth & Insider Trades

Douglas Abel - President and CEO, Manhattan Pharmaceuticals Inc

As of October 24, 2005

What is Douglas Abel's Net Worth?

The current estimated net worth of Manhattan Pharmaceuticals Inc's President and CEO, Douglas Abel, is estimated to be about $14.2K . Douglas Abel owns about 20,000 units of Manhattan Pharmaceuticals Inc common stock. In the last 6 months at Manhattan Pharmaceuticals Inc, Douglas Abel has sold an estimated value of $0 worth.

What is Douglas Abel's Past Insider Trading?

Douglas Abel's largest purchase order was 5,000 units , worth over $7.5K on April 26, 2005. In total, Douglas Abel has made about 5 transactions over 6 months of their time at Manhattan Pharmaceuticals Inc. Douglas Abel usually trades in April, with the busiest year in 2005. The most recent transaction was a purchase order of 5,000 units , worth over $6.55K on October 24, 2005.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Douglas Abel

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Douglas Abel's' Mailing Address?

  • Mailing address is 787 Seventh Avenue, 48th Floor New York NY 10019 NY

What are Manhattan Pharmaceuticals Inc's Past Insider Trades?

Manhattan Pharmaceuticals Inc's most recent insider trade came on October 24, 2005 by Douglas Abel who bought 5,000 units worth $6.55K . In the last year, insiders at Manhattan Pharmaceuticals Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in April, with the busiest year in 2005. The most active traders at the company are Lindsay A. Rosenwald M.D.,  Douglas Abel, President and CEO,  and Neil Herskowitz, Director .

MANHATTAN PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...